Teradyne price target lowered to $150 from $180 at KeyBanc

KeyBanc lowered the firm’s price target on Teradyne (TER) to $150 from $180 and keeps an Overweight rating on the shares. The firm notes shares fell 5.7% following its Q4 results and call. KeyBanc thinks the pullback was driven by 2025 commentary suggesting below-consensus growth on flattish memory market growth and another lower-than-expected forecast for Robotics.